REPL
Replimune Group, Inc.Data: 2026-09-11
Quick Stats
Sep 11, 202644.3
AI Score
HOLD0.8
Volume Ratio
TBA
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
REPL Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
REPL Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
REPL Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REPL Daily Out of Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REPL Daily In the Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REPL Most Active Options by Volume(near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REPL Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
REPL Stock Summary
Last updated Sep 11, 2026
REPL is currently trading at $12.92, positioned above its 200-day moving average of $8.71, indicating a long-term uptrend. The stock has a 52-week range of $1.5 to $16.33.
Technical Analysis: The 50-day moving average stands at $12.57, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 41.967, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.004, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates REPL at 44.3/100 with a HOLD recommendation.
REPL (Replimune Group, Inc.) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 41.967 |
| CMF (20) | -0.004 |
| ROC (10) | -17.179 |
| ADX (14) | 24.758 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.377 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -86.768 |
| MFI (14) | 45.818 |
REPL Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 10 | Marubozu (bearish) (contrarian — textbook says the opposite) | Bullish | 56.2% | +3.2 pts | 30540 |
| Aug 28 | Inverted Hammer | Bullish | 56.4% | +3.4 pts | 19834 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Replimune Group, Inc. is above both the 50 Day and 200 Day SMA which is considered Bullish.
REPL Moving Averages Analysis
Replimune Group, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 11, 2026
Replimune Group, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026
REPL (Replimune Group, Inc.) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 14.82 |
| 20 | 14.95 |
| 30 | 14.28 |
| 50 | 12.57 |
| 100 | 9.49 |
| 200 | 8.71 |
REPL Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.2 billion |
| Earnings/Share ($) | -3.15 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.275 |
| EPS Estimate Next Year ($) | -2.085 |
| WallStreet Target Price ($) | 19.50 |
| Most Recent Quarter |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.